BioSpace News Archive

Business

BMS Bets Big on Eisai’s ADC for Solid Tumors in Potential $3 Billion Collab

Eisai believes this is a potential-best in class FRα ADC that has shown single agent activity in patients with advanced solid tumors, including endometrial, ovarian, lung and breast cancers.

June 18, 2021
·
2 min read
·
Alex Keown
Drug Development

Novartis Study Makes Case for Use of Zolgensma in Presymptomatic SMA Patients

New data shows Zolgensma, Novartis’ gene therapy for spinal muscular atrophy, has the potential to be used presymptomatically in juveniles.

June 18, 2021
·
3 min read
·
Alex Keown
Biomedical Engineering Career Options: Best Opportunities and Career Advice

There are many listings for biomedical engineering jobs on BioSpace. Look at these biomedical engineering career options and choose the perfect career.

June 18, 2021
·
5 min read
·
Lorenzo Soliman
Drug Development

Pfizer’s RA Drug Reduces Death, Respiratory Failure in COVID-19-Related Pneumonia

Findings from the study suggest the oral JAK inhibitor tofacitinib could be a potential contender in the race to identify benefits for COVID-19 in already approved therapies.

June 18, 2021
·
3 min read
·
Brandon May
FDA

Rival Drugs of Biogen’s Aduhelm May Help Prove FDA’s Highly Criticized Approval

Three other drug contenders that work similarly to Biogen’s drug are currently in clinical trials and expecting data relatively soon.

June 18, 2021
·
3 min read
·
Kate Goodwin
HEK 293 Cells: Background, Advantages and Applications

Human Embryonic Kidney 293 (HEK 293) cells are one of the most frequently used cell lines for biotechnology and research studies. These cells are quite popular because of their distinct properties like fast-growing, robustness, and ease of maintenance and transfection.

June 18, 2021
·
4 min read
·
Lorenzo Soliman
Policy

GAO Report Urges Senators to Push for Greater Price Transparency in DTC Drug Ads

In the report to the Committee on the Judiciary in the U.S. Senate, the GAO says drug makers have spent nearly $8.2 billion on DTC drug ads in three therapeutic areas from 2016 to 2018.

June 18, 2021
·
2 min read
·
Brandon May
Business

Athira CEO Placed on Temporary Leave Pending Doctoral Research Review

In its announcement, the company did not specify why Kawas’ doctoral research was under investigation, only saying it did not intend to comment on the issue until it had been resolved.

June 18, 2021
·
2 min read
·
Alex Keown
Drug Development

Orphazyme’s Stocks Tumble After FDA Rejects Genetic Disease Drug Arimoclomol

The FDA said that arimoclomol, which has been studied and submitted for NPC indication, needs further data to support its use in this rare, progressive genetic disorder.

June 18, 2021
·
2 min read
·
Brandon May
European Commission approves Aubagio® (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis

The European Commission (EC) has approved Aubagio® (teriflunomide) for the treatment of pediatric patients 10 to 17 years of age with relapsing-remitting multiple sclerosis (RRMS).

June 18, 2021
·
9 min read